title: Grey spots in a patient with dystrophic epidermolysis bullosa.
authors.forename: A
authors.initials: A
authors.lastname: Schwieger-Briel
authors.forename: D
authors.initials: D
authors.lastname: Kiritsi
authors.forename: H
authors.initials: H
authors.lastname: Schumann
authors.forename: F
authors.initials: F
authors.lastname: Meiss
authors.forename: K
authors.initials: K
authors.lastname: Technau
authors.forename: L
authors.initials: L
authors.lastname: Bruckner-Tuderman
mesh_terms: D000328:Adult; D000891:Anti-Infective Agents, Local / Q000009:adverse effects*; D001129:Argyria / Q000209:etiology / Q000473:pathology; D016108:Epidermolysis Bullosa Dystrophica / Q000150:complications* / Q000188:drug therapy; D005260:Female; D006801:Humans; D012837:Silver Sulfadiazine / Q000009:adverse effects*
chemical_list: D000891:Anti-Infective Agents, Local; D012837:Silver Sulfadiazine